Kodiak Sciences

Found 1 recent publications

Today, Sep 29

Markets

Kodiak Sciences Stock Surges 200% on Positive Phase 3 Trial Results

American biomedical firm Kodiak Sciences saw its stock surge nearly 200% on Nasdaq after reporting positive Phase 3 clinical trial results for its retinal disease treatments.

Showing latest 50 articles for this tag